44 results on '"Peluso, Giusy"'
Search Results
2. Osteoimmunology of Spondyloarthritis.
3. Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
4. Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients
5. Skin ulcers in systemic sclerosis: Determinants of presence and predictive factors of healing
6. Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis
7. B-Cell Subsets in the Joint Compartments of Seropositive and Seronegative Rheumatoid Arthritis (RA) and No-RA Arthritides Express Memory Markers and ZAP70 and Characterize the Aggregate Pattern Irrespectively of the Autoantibody Status
8. Body weight, gender and response to TNF-α blockers in axial spondyloarthritis
9. A vascular endothelial growth factor deficiency characterises scleroderma lung disease
10. The human salivary proteome: a critical overview of the results obtained by different proteomic platforms
11. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease
12. Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression
13. Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis
14. Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios
15. Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome
16. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis
17. Inclusion of Synovial Tissue–Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment‐Naive Rheumatoid Arthritis Patients.
18. Analysis of response to infliximab in ankylosing spondylitis according to the axial and/or peripheral involvement: autoantibodies and drop outs are more frequent in the peripheral subset
19. Hepatocyte Growth Factor and Transforming Growth Factor β1 Ratio at Baseline can Predict Early Response to Cyclophosphamide in Systemic Lupus Erythematosus Nephritis
20. β-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up
21. PsA-Disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients: an Italian derma-rheuma multicentre study.
22. Silent acro-osteolysis in a patient with psoriatic disease and recurrent micro-trauma.
23. B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status
24. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
25. Baseline Shoulder Ultrasonography Is Not a Predictive Marker of Response to Glucocorticoids in Patients with Polymyalgia Rheumatica: A 12-month Followup Study.
26. Thymosin β4 and β10 in Sjögren's syndrome: saliva proteomics and minor salivary glands expression.
27. Analysis of response to infliximab in ankylosing spondylitis according to the axial and/orperipheral involvement: autoantibodies and drop outs are more frequent in the peripheral subset
28. Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission.
29. Telemedicine will not keep us apart in COVID-19 pandemic.
30. Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: An aggressive tight control therapy not fully arresting the disease.
31. Proteome analysis of biological fluids from autoimmune-rheumatological disorders.
32. β-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up.
33. β-thymosins and interstitial lung disease: a study of a sclerodema cohort with a one-year follow-up.
34. Proteomic approaches to Sjögren's syndrome: A clue to interpret the pathophysiology and organ involvement of the disease
35. Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis
36. Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship?
37. No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic.
38. One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study.
39. Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica.
40. Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy.
41. Thymosin β 4 and β 10 in Sjögren's syndrome: saliva proteomics and minor salivary glands expression.
42. Proteome analysis of biological fluids from autoimmune-rheumatological disorders.
43. Analysis of response to infliximab in ankylosing spondylitis according to the axial and/or peripheral involvement: autoantibodies and drop outs are more frequent in the peripheral subset.
44. Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.